Microneedles permit transdermal delivery of a skin-impermeant medication to humans
about
Microneedles: A New Frontier in Nanomedicine DeliveryMicroneedles for intradermal and transdermal drug deliveryMicro-scale devices for transdermal drug deliveryChallenges and opportunities in dermal/transdermal delivery.Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.Impact-insertion applicator improves reliability of skin penetration by solid microneedle arrays.Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs.Transdermal delivery of proteinsZnO Nano-Rod Devices for Intradermal Delivery and Immunization.Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms.Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.Programmable transdermal drug delivery of nicotine using carbon nanotube membranes.Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunityTransdermal insulin delivery using microdermabrasionKinetics of skin resealing after insertion of microneedles in human subjects.Transdermal patches: history, development and pharmacology.Skin needling to enhance depigmenting serum penetration in the treatment of melasmaMicro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns.Microneedles for drug and vaccine deliveryReleasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion.Diclofenac delays micropore closure following microneedle treatment in human subjectsDiclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.Transdermal drug delivery.Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles.Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug DeliveryMicroneedles: a valuable physical enhancer to increase transdermal drug delivery.Controlled delivery systems: from pharmaceuticals to cells and genes.Microneedle arrays as medical devices for enhanced transdermal drug delivery.The role of microneedles for drug and vaccine delivery.Characterization of microchannels created by metal microneedles: formation and closure.In vitro and transdermal penetration of PHBV micro/nanoparticles.Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population.Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery
P2860
Q26767037-A14081BB-A17A-4798-AE63-D4558610F638Q26995148-2190CF10-1CF7-484F-9DBC-160DD8821265Q27489779-001E4EFC-724D-44E1-AC9D-FAE04FBACC29Q30432573-F6A74FA7-A592-4CB2-AC51-84E9E4CAFD77Q30487666-13A55B9A-0757-4D3C-8763-F90C2CBFF7BBQ33572370-57E6D1FB-AFE2-4293-928B-C06BA42B8DE8Q33804013-6D33F159-78D8-4A2B-8D43-106D3AF8FA10Q33805053-ADD3B396-48DC-4BD8-96A5-FD88B874757DQ33820475-3A678036-E34F-4D04-8190-6FDE3B45F6BAQ33835912-387394E6-20C6-4008-A859-7B04A8A14691Q33837944-79E18196-BF3F-43CD-9A15-884E1426A9CAQ33942053-5618576F-1E44-4E7A-B9EF-3861482C47A1Q33975431-D01F4AEC-066D-44FF-BD9F-3FC07531DC0AQ33977922-1A4CD80C-1E88-4FA9-8CC9-49A489EF156AQ34005731-DE938A64-F5C9-4D34-B431-5EE713DDD4EBQ34038849-8DD83908-DDD3-492D-A02D-709BF9E057FAQ34175719-B7E52CF3-BCD4-4D0B-96FE-E22D197B25DFQ35154112-FC8FE11A-F0E7-4B1F-AC3B-F09C0E791BC6Q35187866-549EBCFF-790A-4448-9D1E-1A7E325BBE7EQ35484265-D986A3B6-3230-4054-8C96-B54B90501634Q35909904-116222A9-459E-4AD3-A795-C36FB5A73E47Q36105260-AE789146-A1F4-467A-8584-9DA7BF554DB3Q36164749-181C7D1E-1B8E-4F54-88FB-1388F0CC38CBQ36331113-07224A8F-345D-42BA-9EA9-84A065DD883BQ36918266-776E8A1E-AA57-41CC-A348-E270567EA2ADQ37051274-852EFB87-7AFA-4B88-832C-A28864FFFEDBQ37173681-392D1F12-1F9C-4936-863F-449EA6620F25Q37238479-28E03AC2-830A-4395-AF16-1DA503D2369BQ37316009-59910A1F-6CD5-412E-9034-66D96CB3758CQ37359303-B132941E-B1ED-49E4-85FF-243C5FDCEDC2Q37426334-6780B214-AD2D-4C49-BFDF-82DFE40CDFEAQ37483873-55465438-732E-468B-ADA6-2B4BF9CAEFC4Q37819486-686A1CE7-B2D6-492A-9C2B-1F6BA5E481E0Q37855597-1C29CC67-07C7-4740-8DF0-7B8E83BFB01FQ37897542-C25F01BC-9A16-46E0-BB3E-481E037D19CFQ38229145-35F4B6FC-D22C-4B0D-81F9-D10079C5BFF7Q38254574-6E3E6CE7-01F9-43E7-94D9-09589EAD81E0Q39025731-6AC245F4-D240-474F-8F3C-BA69BBFF2907Q39173094-75BA6A0C-052F-41F1-831C-ED59F5ED7FDBQ41781622-88A6B8F2-8028-40EC-A0D9-AA17C7B16D79
P2860
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
@en
type
label
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
@en
prefLabel
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
@en
P2093
P2860
P356
P1476
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
@en
P2093
Audra L Stinchcomb
Daniel P Wermeling
David A Hudson
Harvinder S Gill
Jyoti Gupta
Mark R Prausnitz
Stan L Banks
P2860
P304
P356
10.1073/PNAS.0710355105
P407
P577
2008-02-04T00:00:00Z